Actinic Keratosis- Red Light Photodynamic Research Study

We know these are challenging times and venturing out can be especially stressful. We want you to know that at CRCC we have implemented every safety measure possible to keep you safe and prevent the spread of Covid-19. Patient areas are continually disinfected, social distancing is enforced in our lobby, and all staff wear masks/gloves throughout the day. If you arrive for your appointment and wish to wear a mask, we will provide one for you as well.

• Open-label, Ameluz® with red light photodynamic therapy (PDT) in the treatment of actinic keratosis (AK) on the extremities and neck/trunk
• Expanded field directed treatment
• Mild to moderate AK with at least 4-15  clinically confirmed mild to moderate lesions with a diameter of ≥ 4 mm on the extremities and neck/trunk
• 18 years and older
• 80% chance of being on active treatment vs 20% placebo
• Up to 2 treatments
• No history of peanut or soy allergy
• 6-8 visits total 

If you are interested in participating in one of these studies, please provide your contact information below. If you are a qualified candidate, a representative from our research department will be in touch with you.